The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain
A. E. van Vlimmeren, R. Voleti, C. A. Chartier, Z. Jiang, D. Karandur, P. A. Humphries, W.-L. Lo, N. H. Shah
This paper investigates the T42A mutation in SHP2, showing it alters ligand-binding specificity in the N-terminal SH2 domain, leading to biased activation and enhanced signaling.
bioRxiv · Jul 10, 2023Biochemistry